Abstract. We have raised two monospecific antibodies against synthetic peptides derived from the membrane domain of the ER glycoprotein 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase, the rate limiting enzyme in the cholesterol biosynthetic pathway. This domain, which was proposed to span the ER membrane seven times (Liscum, L., J. FinerMoore, R. M. Stroud, K. L. Luskey, M. S. Brown, and J. L. Goldstein. 1985. J. Biol. Chem. 260:522-538), plays a critical role in the regulated degradation of the enzyme in the ER in response to sterols. The antibodies stain the ER of cells and immunoprecipitate HMG-CoA reductase and HMGal, a chimeric protein composed of the membrane domain of the reductase fused to Escherichia coli/3-galactosidase, the degradation of which is also accelerated by sterols. We show that the sequence Arg TM through Leu 242 of HMG-CoA reductase (peptide G) faces the cytoplasm both in cultured cells and in rat liver, whereas the sequence Thr TM through Glu m (peptide H) faces the lumen of the ER. This indicates that a sequence between peptide G and peptide H spans the membrane of the ER. Moreover, by epitope tagging with peptide H, we show that the loop segment connecting membrane spans 3 and 4 is sequestered in the lumen of the ER. These results demonstrate that the membrane domain of HMG-CoA reductase spans the ER eight times and are inconsistent with the seven membrane spans topological model. The approximate boundaries of the proposed additional transmembrane segment are between Lys 24s and Asp 276. Replacement of this 7th span in HMGal with the first transmembrane helix of bacteriorhodopsin abolishes the sterol-enhanced degradation of the protein, indicating its role in the regulated turnover of HMG-CoA reductase within the endoplasmic reticulum.
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3-HYDROXY-3-METHYLGLUTARYL coenzyme A (HMGCoA) t reductase catalyzes the conversion of HMG-CoA to mevalonate (Durr and Rudney, 1960) , the precursor for a wide variety of metabolites that play central roles in cellular functions. These products of the mevalonate pathway include sterols, ubiquinone, dolichols, isopentenyladenine, heme A and the isoprenyl moieties of proteins (for a recent review see Goldstein and Brown, 1990) . In mammalian cells, HMG-CoA reductase is the major regulatory enzyme in this pathway and is subject to complex metabolic control ensuring an adequate supply of intermediates and products of this pathway. This is achieved by regulation of transcription of the HMG-CoA reductase gene (Liscum et al., 1983a; Osborne et al., 1985) , regulation of translation of its mRNA (Tanaka et al., 1983; Petfley and Sinensky, 1985; Nakanishi Shoshana Bar-Nun is a visiting Scholar from the Department of Biochemistry, George S. Wise Faculty of Life Sciences, Tel Aviv University, Ramat Aviv 69978, Israel.
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HMG-CoA, 3-hydroxy-3-methylglutaryl coenzyme A; PPD, purified protein derivative; SLO, streptolysin O. et al., 1988) , controlled degradation of the reductase protein (Sinensky and Logel, 1983; Edwards et al., 1983; Gil et al., 1985; Chin et al., 1985) , and modulation of enzyme activity (Hardie et al., 1989; Roitelman and Shechter, 1984) .
Through cloning of its cDNA, the primary structure of HMG-CoA reductase from many eukaryotes, including yeast (Basson et al., 1988) , plants (Learned and Fink, 1989; Caelles et al., 1989) , fly (Gertler et al., 1988) , schistosomes (Rajkovic et al., 1989) , sea urchin (Woodward et al., 1988) , frog (Chen and Shapiro, 1990) , rodents Skalnik and Simoni, 1985) , and humans (Luskey and Stevens, 1985) has been deduced. Mammalian HMG-CoA reductase is a 97-kD membrane-bound "high mannose" glycoprotein of the ER (Liscum et al., 1983b; Brown and Simoni, 1984) . The enzyme is co-translationally inserted into the ER membrane in a signal recognition particledependent manner (Brown and Simoni, 1984) , and it lacks a cleavable signal sequence (Brown and Simoni, 1984; Chin et al., 1984) . Under certain conditions, the enzyme appears to function as a homodimer (Edwards et al., 1985; Ness et al., 1985; Roitelman and Shechter, 1986) . The catalytic site, Elevated cellular levels of HMG-CoA reductase and HMGal were induced, as described above. Cells were washed twice in PBS and fixed in 2 % (wt/vol) paraformaldehyde in PBS for 15 min at room temperature. Excess paraformaldehyde was neutralized with 100 mM NI-14CI for 10 min, and the cells were further washed three times with PBS. Selective permeabilization of the plasma membrane was achieved by one of the following protocols: (a) 15 min on ice with 10 #g/nil digitonin in 0.3 M sucrose/0.1 M KC1/2.5 mM MgCI2/1 mM EDTA/10 mM Pipes, pH 6.8; (b) 15 min on ice with 10 U/ml of SLO in PBS/2 mM DTT. The SLO solution was then removed and cells were incubated in fresh PBS at 37~ for an additional 10 min; (c) semi-intact cells prepared by the nitrocellulose overlay method (Beckers et al., 1987; see below) . Complete permeabilizatinn of cellular membranes of fixed cells was by treatment with 0.25% Triton X-IO0 in PBS for 5 rain on ice. After permeabilization by either protocol, the cells were washed three times with PBS and incubated with 5% BSA in PBS for 1 h at room temperature. The blocking solution was removed and fresh BSA solutions containing primary antibodies, at the appropriate dilution, were added and allowed to incubate at room temperature for 1 h. The cells were washed three times in 0.5 % BSA/PBS, and fluorescent secondary antibodies were added in 5% BSA/PBS for 2 h. After three washes in 0.5% BSA/PBS and an additional three times in PBS, the coverslips were rinsed in H20 and mounted on glass slides in a drop of mounting solution (25 mg/ml of 1,4-diazobicyclo[2.2.2]-octane in 90% glycerol/0.1 M Tris-Cl, pH 9; Johnson et al., 1982) . Cells were viewed and photographed in a Zeiss epifluorescence microscope (Carl Zeiss, Oberkochen, Germany).
Semi-intact Cells
The medium of CHO-HMGal cells, grown as a monolayer in 30 mm dishes, was aspirated and circles of nitrocellulose, pre-wetted in PBS, and blotted between sheets of Whatman paper for 5 s under a pressure of about 1 kg, were overlaid on top of the monolayer for 60 s. The nitrocellulose was then gently lifted from the monolayer and the cells were processed for immunofluorescence analysis, as described above. For microscopy, a drop of mounting glycerol solution was added to the dish and a glass coverslip was placed on top of the monolayer. Cells were viewed while on the dish.
Construction of HMGal/Dins(A )
HMGai/Dins(A) is a mutant of HMGal in which the sequence His 26s through Glu 3~ (overlapping the H epitope and the native glycosylation site of HMG-CoA reductase) has been moved from its native position into the D loop segment connecting the putative 3rd and 4th membrane spans (Liscure et al., 1985) of HMG-CoA reductase (i.e., in between residues Thr 119 and Glum23; see Figs. 1 and 8). This mutant was constructed as follows: the EcoR1/Pstl DNA fragment of pSRa-HMGal (HMGal cloned in pcDLSRa296 (Takebe et al., 1988) ; Chun and Simoni, 1992) , which encodes the entire membrane domain of HMG-CoA reductase (residues 1-449), was subeloned into the muitifunctional phagemid pTZ18R to yield pTZ-HM. Through site-directed mutagenesis, a unique Nhel site (underlined) was created after Thr Hg, using the mutagehic oligonncleotide 5'-AAAGAACTGACA~TAGCTGAAGCTTTGCCC-3'. The native H epitope (the sequence Thr TM through Glu 3ez) was destroyed by site-directed deletion using the 36mer 5'-TCCCCTCAGAACAGCACA/CCAAGTGT-TTCTCTCTGG-3' (where / indicates the site of deletion), bridging Thr ~s3 and pro303. The mutated membrane domain was swapped, as an EcoR1-Pstl fragment, with the wild-type membrane domain back into pSRaHMGal, creating pSRotHMGal(NheAH). A DNA which includes the sequence encoding His 26s through Glu 3~ was generated by annealing four oligonucleotides comprising tva~ self-complementary sets (underlined nucleotides denote Nhel overhangs): 5'-CTAGC~TCTAGACATGCTCACAGTCGCTGG-ATAGCTGATCCTTCCCCTCAG-3' and 3'-CCAGATCTGTACGAGTGTC-AGCGACCTATCGACTAGGAA~AGTCTTGTCGTGT-5' and 5'-AA-CAGCACAACAGAACATTG TAAAGTTTC C TTGC~AC TAGATGAAGAT-GTGTCCAAGAGAATTGAA-Y and YTGTCTTGTAACATT'ICAAAGG-AACC C TGATCTAC T TCTACACAGGTTC TCTTAAC TTGATC -5'. This ll3-bp DNA was inserted into the Nhel-cut pSR~HMGal(NheA). The modified sequence in this region reads: . . . Thrllg(Gly)(Ser)(Arg)-His 26s .... Ghi3~ 123 ..... where the residues indicated in parentheses were engineered into the oligonucleotides to create a diagnostic Xbal restriction site and to maintain the reading frame. The desired mutations were confirmed by restriction analyses and DNA sequencing of the relevant regions.
Transient expression of HMGal and HMGal/Dins(A ) in COS Cells
For metabolic labeling, sub-confluent COS cells, grown in 150 nun dishes in DME containing 5% FCS, were transfected with 100 #g of wild-type pSRc~HMGai or pSRaHMGal/Dins(A) by the calcium phosphate precipitation method (Graham and van der Eb, 1973) . In separate experiments we have established that maximal expression of ~-galactosidase activity of the chimeric proteins is reached 3 d after transfection. Two days after transfection, the cells were refed with Induction Medium. On the third day, the cells were switched to methionine-free MEM containing 5 % LPS and compactin and mevalonate and starved for 1 h. Cells were then pulsed with 250 #Ci of Tran35S-label (125 #Ci/ml) for 2 h at 37"C. Cells were washed three times in PBS and lysed and processed for immunoprecipitation, as previously described (Chnn et al., 1990) .
For immunofluorescence studies, COS cells were plated on glass coverslips in 60-mm dishes and transfected with plasmid DN~s, as described above. On the second day posttransfection, the coverslips were removed and inserted to individual wells of 24-well dishes and the cells were refed with 1 ml of Induction Medium. On the third day, cells were washed and processed for immunofluorescence inspection.
Immunogold Cytochemistry
Rats, adapted to 12 h dark/12 h light cycle, were fed ad libitum powdered chow containing 5 % (wt/wt) cholestyramine resin. After 5 d, the diet was switched to chow containing 5% (wt/wt) cholestyramine and 0.2% (wt/wt) compactin for an additional 2 d. This diet regimen has been shown to increase hepatic levels of HMG-CoA reductase (Tanaka et ai., 1982; Clark et al., 1984) . Near the end of the dark cycle, the animals were anesthetized with ether and their livers perfused in situ with saline then with fixative solution (0.1% glutaraidehyde/0.2% picric acid/0.5 mM CaC12 in 0.1 M NaPO4, pH 7.4). Portions of the liver, minced into 1 mm 3 cubes, were postfixed for an additional 4 h. The cubes were washed, stained en bloc with uranyl acetate, dehydrated, and embedded in LRGold, as described by Berryman and Rodewald (1990) . Immunocytochemical localization of the G and H epitopes was done following procedures outlined by Berryman and Rodewald to enhance cell membrane contrast (Berryman and Rodewald, 1990) . Briefly, ultra-thin sections of embedded tissue were incubated overnight with the primary antibodies diluted in 5 % normal goat serum in TBS. After washes, the sections were incubated with goat anti-rabbit IgG conjngated to 5 nm colloidal gold, postfixed with 2% glutaraldehyde and 2% osmium tetroxide, and then stained with lead citrate.
Results

Antibodies against Peptides in the Membrane Domain of HMG-CoA Reductase
The current topological model for the membrane domain of hamster HMG-CoA reductase, schematically drawn in Fig.  1 A, is based on hydropathy plots of the amino acid sequence of the NH2-terminal 350 residues (Liscum et al., 1985 ). An alternative model, which has recently emerged from our laboratory (Olender and Simoni, 1992) , is depicted in Fig. 1 B. The major difference between the two models is the existence of an additional membrane span between the putative 6th and 7th spans of the original model, increasing the total number of spans to 8, and thereby reversing the orientation of spans 1-6 (Olender and Simoni, 1992).
To test the 8-span model by an independent approach, we prepared antibodies against synthetic peptides corresponding to several regions in the membrane domain of HMGCoA reductase. The peptides were coupled to PPD which elicits a strong immune response, yet does not give rise to antibodies against itself (Lachmann et al., 1986) Skalnik and Simoni, 1985) . The antibodies produced are designated anti-G and anti-H, respectively.
Both anti-G (Fig. 2 , lane/) or anti-H (Fig. 2 , lane 3) immunoprecipitate two proteins of M, 97,000 and 150,000 from 3sS-labeled CHO-HMGal lysates. The mobilities of Figure 2 . Specificity of anti-G and anti-H antibodies. CHO-HMGal cells were grown in Induction Medium for 24 h before the experiment. Cells were starved for 1 h in methionine-free MEM and then labeled for 4 h with 150 ~Ci of [35S]methionine (0.5 mCi/ml; 0.3 ml). Cells were washed and lysed, as described (Chun et al., 1990) . After centrifugation, the cleared post-nuclear lysate was divided to five equal aliquots and 5/d of anti-G (lanes I and 2), anti-H (lanes 3 and 4) IgGs or a 1:1 mixture of anti-reductase and anti-/3-galactosidase (lane 5) antibodies were added. For peptide competition, 50/~g of free peptide G (lane 2) or peptide H (lane 4) were added to the cell lysate. Immunoprecipitation was carded out as described (Chun et al., 1990) , and precipitates were resolved by 8% SDS-PAGE. Relative molecular weight standards are indicated on the fight hand side. HMGR, HMG-CoA reductase and HMGal, the fusion protein between the membrane domain of HMG-CoA reductase and/3-galactosidase, are indicated by arrowheads. these bands in SDS gels are consistent with the sizes of HMG-CoA reductase (97 kD; Hardeman et al., 1983; Chin et al., 1984; Skalnik and Simoni, 1985) and HMGal (150 kD; Skalnik et al., 1988) . These proteins were specifically precipitated as they were competed by an excess of the corresponding free peptides (Fig. 2, lanes 2 and 4) . Furthermore, the same proteins were precipitated with a mixture of antibodies directed against/~-galactosidase and the cytoplasmic domain of HMG-CoA reductase (Fig. 2 , lane 5). The latter antibody mixture, unlike the anti-peptide antibodies, also precipitated a ,~63-kD protein (Fig. 2) , most likely the cytoplasm-facing proteolytic fragment of HMG-CoA reductase (Hardeman et al., 1983; Liscum et al., 1985) .
To demonstrate unequivocally that the anti-peptide antibodies react with HMG-CoA reductase and HMGal, we carried out an immunodepletion experiment in which 35S-labeled lysates of CHO-HMGal cells were first incubated with one antibody followed by removal of the immune complex. The supernatant solution was then taken through a second round of immunoprecipitation with a different antibody (Fig.  3) . When pre-immune sera were used in the first round of precipitation ( Fig. 3 A, lanes I and 9) , anti-G and anti-H precipitated the 97-and 150-kD proteins in the second precipitation step (Fig. 3 A, lanes 2 and 10, respectively) . When the lysate was first treated with anti-G (Fig. 3 A, lanes 3 , 5, and 7), neither bands were precipitated in the second step with either anti-H (Fig. 3 A, lane 4) , anti-HMG-CoA reductase (Fig. 3 A, lane 6) , or anti-/3-galactosidase antibodies (Fig.  3 A, lane 8) . Conversely, immunoprecipitation with the anti-H antibody (Fig. 3 A, lanes 11, 13, and 15 ) depleted the lysate of the 97-and 150-kD proteins, such that they could not be further immunoprecipitated by either anti-G (Fig. 3  A, lane 12) , anti-HMG-CoA reductase (Fig. 2 A, lane 14) , or anti-/3-galactosidase (Fig. 3 A, lane 16) . In Fig. 3 B it is demonstrated that initial immunoprecipitations with anti-HMG-CoA reductase (Fig. 3 B, lanes 3 and 9) or with anti-/5-galactosidase (Fig. 3 B , lanes 5 and 1/) antibodies do not allow the subsequent precipitation of the 97-and 150-kD proteins by either anti-G (Fig. 3 B , lanes 4 and 6) or anti-H (Fig. 3 B, lanes 10 and 12) antibodies, respectively. It should be noted that anti-HMG-CoA reductase antibody also immunoprecipitates HMGal (Fig. 3 B, lanes 3 and 9) . This polyclonal antibody was raised against the purified 52-kD cytoplasmic fragment of rat liver HMG-CoA reductase (Jenke et al., 1981) which has been recently shown to be generated by proteolysis at Ser 423 of the hamster sequence (Clarke and Hardie, 1990) . In the construction of the After incubation overnight at 4~ Protein A bacterial adsorbent was added aed further incubated for 2 h at 4~ The tubes were spun at 16,000 g for 10 rain, the supernatants were carefi~y transferred into new tubes and were either analyzed by SDS-PAGE or supplemented with different antibodies, as follows: (2ndAb): Anti-G, A, lanes 2 and 12 and B, lanes 2, 4, and 6; anti-H, A, lanes 4 and 10 and B, lanes 8, 10, and 12; anti-HMG-CoA reductase, A, lanes 6 and 14; anti-B-galactosidase, A, lanes 8 and 16. The second immunoprecipitation step was carried out overnight at 4~ followed by addition of Protein A bacterial adsorbent, as described above. All immunoprecipitates were processed and resolved simultaneously by 8 % SDS-PAGE. Relative molecular weight standard is indicated on the right hand side. HMG-CoA reductase (HMGR) and HMGal (HMGal) are indicated by the arrowheads.
HMGal chimera, B-galactosidase was cloned at position 449 in the hamster reductase sequence (Skalnik et al., 1988) , therefore this anti-HMG-CoA reductase polyclonal antibody most likely reacts also with the region between Ser .23 and Gln 44~ in HMGal.
These results demonstrate that the 97-and 150-kD proteins correspond to HMG-CoA reductase and HMGal, respectively, and that anti-G and anti-H antibodies specifically recognize the membrane domain of these proteins.
Anti-G and A n t i -H Stain E R
By indirect immunofluorescence (Fig. 4, A-F) , anti-G (C), and anti-H (E) stain fixed and Triton X-100-permeabilized C100 cells in a manner indistinguishable from the staining obtained with either polyclonal (A) or mAbs (B) directed against the cytoplasmic domain of HMG-CoA reductase. C100 cells are a variant of an SV-40-transformed BHK cell line which was adapted to grow in the presence of 225 #M compactin. As a result, these cells exhibit some 100-fold increased HMG-CoA reductase activity (Hardeman et al., 1983) . Anti-G and anti-H, as well as the anti-HMG-CoA reductase antibodies, stain the nuclear envelope and a perinuclear reticulum of C100 cells. Associated with this reticulum and surrounding the nucleus are numerous intensely labeled inclusions resembling the appearance of crystalloid ER in UT-1 cells (Chin et al., 1982; Anderson et al., 1983; Pathak et al., 1986) . The binding of anti-G or anti-H is specific since it could be blocked by an excess of the corresponding antigenic peptides (Fig. 4, D and F, respectively) .
Additionally, the images in Fig. 4 G show that in CHOHMGal cells, staining with anti-B-galactosidase antibodies also reveals a lacy structure throughout the cytoplasm, characteristic of ER, with occasional staining of the nuclear envelope. Associated with the ER are also several regions of intense fluorescence that surround or appear on opposite sides of the nucleus (Fig. 4 G) , similar to the ones observed in C100 cells. The A9 monoclonal anti-reductase antibody identifies the same structures in CHO-HMGal cells (Fig. 4  H) , indicating that HMGal and HMG-CoA reductase are colocalized in the same intracellular membranes. It should be noted that CHO-HMGal cells have been taken through several rounds of fluorescence-activated cell sorting to isolate population of cells expressing high HMGal activity (Chun et al., 1990) . Thus, the elevated levels of HMGal in these cells may have caused proliferation of the ER similar to that observed in cells that express high levels of HMG-CoA reductase (Chin et al., 1982) .
G Epitope Faces the Cytoplasm in Cultured Cells and in R a t Liver
To determine the sidedness of the binding of anti-G and anti-H antibodies to the membrane domain of HMGal/HMG-CoA reductase, we used three different protocols for permeabilizing the plasma membrane without compromising the integrity of the ER (see Materials and Methods).
Digitonin Permeabilization. Fixed CHO-HMGal cells were permeabilized with low concentrations of digitonin. Digitonin, which complexes with B-hydroxysterols, should perforate preferentially (but not exclusively) the plasma membrane because of its high content (~90%) of cellular free cholesterol (Lange, 1991) . The permeabilized cells were stained simultaneously with mouse monoclonal anti-B-galactosidase antibody and with rabbit anti-G or anti-H antipeptide antibodies, followed by species-specific fluorescent secondary antibodies. Inasmuch as anti-H antibody reacts with a lumenal epitope adjacent to the single N-glycosylation site of HMG-CoA reductase (Liscum et al., 1983b; Brown and Simoni, 1984) or HMGal (Skalnik et al., 1988; Olender and Simoni, 1992) , this antibody should not gain access to its epitope when the ER membrane remains intact. The mouse antibody, which reacts with the cytoplasmically disposed/3-galactosidase domain of HMGal, serves as a control for accessibility of antibodies to the cell interior. Mild treatment with digitonin (5-10 #g/ml) allows staining of HMGal by the anti-/3-galactosidase antibody, with no significant binding of anti-H antibody to the membrane domain of the enzyme (Fig. 5, C and D) . A and B of Fig. 5 show that, in cells which are first permeabilized with digitonin and then treated with Triton X-100, anti-H stains the same intracellular structures as does anti-/~-galactosidase antibody, demonstrating that the inability of anti-H to stain the cells in D is because of inaccessibility of the antibody to its cognate epitope in the lumen of the ER (see below). Anti-G antibody, on the other hand, recognizes HMGal in digitonin-permeabilized cells (Fig. 5 F) as effectively as it does in Triton X-100-treated cells (Fig. 5 H) , and stains the ER as intensely as does anti-~-galactosidase antibody (Fig. 5, E and G). These results demonstrate that, under conditions where lumenal epitopes are inaccessible to antibodies, the G epitope is readily exposed to antibodies in the cytoplasm. Similar differential staining with anti-H and anti-G in digitoninpermeabilized CHO-HMGal cells was obtained when we used the TUB2.1 monoclonal anti-~-tubulin antibody to assess accessibility to cytoplasmic epitopes (data not shown).
To rule out the remote possibility that the antigenicity of the G or H epitopes in the membrane domain of HMG-CoA reductase/HMGal has been altered by digitonin, we used alternative protocols for selective permeabilization of the plasma membrane.
Permeabilization by Streptolysin O. Streptolysin O (SLO), a pore-forming toxin produced by hemolytic streptococcus, was successfully used for selective permeabilization of the plasma membrane (Ahnert-Hilger et al., 1989 ). We applied reduced SLO to fixed CHO-HMGal cells at 0~ After removing excess toxin, the cells were warmed to 37~ and processed for immunofluorescent analysis, as described under Materials and Methods. That pores large enough to allow passage of antibodies to the cytoplasmic compartment were generated is indicated by the specific staining by the anti-Bgalactosidase antibody (Fig. 6, A and C) . Under these conditions, however, ER lumenal epitopes remain cryptic, as indicated by lack of staining by anti-H antibodies (Fig. 6  B) . Nevertheless, the G epitope is fully exposed to anti-G antibodies, as demonstrated by the fluorescent labeling of the same structures that house HMGal (Fig. 6, compare  D with C) .
Semi-intact Cells. CHO-HMGal cells, grown on plastic dishes, were rendered semi-intact by the nitrocellulose overlay method, essentially as described by Beckers et al. (1987) . By this method large perforations are created in the cell surface when portions of the plasma membrane are peeled away by an overlaid nitrocellulose filter. Such large pores allow direct access of antibodies to the cytoplasmic domain of the cell (Beckers et al., 1987) . In Fig. 6 we show that antibodies did indeed gain access to the cytoplasm of the semi-intact CHO-HMGal cells, as indicated by the staining of HMGal by anti-/%galactosidase antibody (Fig. 6 , E and G). That the integrity of the ER membrane was maintained is indicated by the lack of specific staining by anti-H antibody (Fig. 6  F) . Again, the G epitope was cytoplasmically accessible to anti-G antibody (Fig. 6 H) .
Rat Liver. Next, we examined the membrane sidedness of the G and H epitopes in situ by immunogold labeling of rat liver sections with the anti-peptide antibodies (Fig. 7) . Both anti-G and anti-H antibodies label almost exclusively smooth tubules and vesicles of variable sizes and shapes located throughout the cell. Labeling was not present over mitochondria, peroxisomes, nuclei, or Golgi cisternae, but was found over some regions of rough ER (not shown). When using anti-G antibody, labeling is restricted to the cytoplasmic surfaces of these vesicles (Fig. 7 A) . Contrary, the epitope recognized by anti-H antibody is found almost exclusively on the lumenal surfaces (Fig. 7 B) . Thus, the results obtained from rat liver are consistent with those observed in cultured cells, demonstrating that epitope G faces the cytoplasmic surface of the ER.
The Loop Region between the 3rd and 4th Membrane Spans Is Lumenal
The results presented above demonstrate that the G epitope is exposed to the cytoplasm whereas the H epitope is lumenal, indicating that the G and H epitopes are separated by a membrane spanning segment (see Fig. 1 B) . This is in contrast to the current topological model for the membrane spanning domain of HMG-CoA reductase in which both epitopes reside in the lumen of the ER (Liscttm et al., 1985;  see Fig. 1 A) . Moreover, these data strongly suggest that the l~gure 4. Anti-G and anti-H antibodies specifically identify endoplasmic reticulum in C100 and CHO-HMGal ceils. CIO0 (A-F) or CHOHMGal (G and H) cells, grown on glass coverslips, were fixed and permeabilized with 0.25% Triton 3[-100, as described under Materials and Methods. C100 cells were stained with polyelonal rabbit anti-rat HMG-CoA reduetase antibodies (.4) or with the A9 mouse anti-hamster HMG-CoA reductase mAb (B). Cells were stained with anti-G antibody with (D) or without (C) 50 #g of competing peptide G, or with anti-H antibody with (F) or without (E) 50 #g of competing peptide H. CHO-HMGal cells were stained simultaneously with rabbit anti-/3-galactosidase antibodies (G, FITC-labeled secondary antibody) or with the A9 antibody (H, rhodamine-labeled secondary antibody).
orientations of the membrane spans NH2-terminal to epitope G are reversed relative to the plane of the ER membrane. To test this directly, we deleted the H epitope from its native position between the glycosylation site and the last membrane span, and moved it into the loop region bridging spans three and four (see scheme in Fig. 8, bottom) . According to the seven spans model, this epitope should be exposed to the cytoplasm. COS cells were transfected with pcDLSRct plasmid carrying this mutated HMGal/Dins(A) chimeric gene. In parallel, we transfected COS cells with the wildtype pSRczHMGal. Fig. 8 shows that HMGal/Dins(A) is expressed in amounts comparable to those of wild type HMGal (compare lanes I and 4) . Moreover, both anti-G (lanes 2 and 5), and anti-H 0ones 3 and 6) antibodies precipitate the mutant and the wild type HMGal. These results suggest that the mutation in HMGal/Dins(A) does not grossly affect its recognition by antibodies or stability. (The higher molecular size of HMGal/Dins(A) is expected due to the fact that a net of 20 residues were added to the protein (see Materials and Methods).
Next, the plasma membrane of the cells expressing HMGal/Dins(A) was selectively permeabilized with SLO, or cells were fully permeabilized with Triton X-100. The cells were immunofluorescently stained with a mixture of anti-/3-galactosidase and anti-H antibodies (Fig. 9 ). Clearly, while the H epitope was fully accessible to anti-H antibodies in Triton X-100-permeabilized cells (Fig. 9 F) , this epitope was not recognized in SLO-permeabilized HMGal/Dins(A) cells (Fig. 9 D) , demonstrating that the H epitope in its altered position is still sequestered in the lumen of the ER, just as it is in its native position (Fig. 9 B) . Taken together with our recent finding that a similar mutant, HMGal/Dins(-), is glycosylated in vivo (Olender and Simoni, 1992 ), these results demonstrate that the loop region between the putative 3rd and 4th membrane spans is lumenally disposed.
The Sequence between the G and the H Epitopes Is Involved in the Sterol-accelerated Degradation of HMGal
The results presented above demonstrate that the G and the H epitopes are separated by a transmembrane-spanning region. Since the membrane domain of HMG-CoA reductase plays a critical role in the turnover of HMG-CoA reductase and of HMGal, we compared the regulated degradation of a mutant in which this putative transmembrane segment (Gin TM through Trp 273) has been replaced with the first transmembrane span of bacteriorhodopsin (Span7-HMGal; Chun and Simoni, 1992) . Fig. 10 shows that the B-galactosidase activity of wild type HMGal rapidly drops to '~25-30% of initial activity within 24 h after addition of excess sterols to CHO-HMGal cells. We have previously shown that this drop in activity is a result of accelerated degradation of HMGal (Skalnik et al., 1988; Chun et al., 1990; Inoue et al., 1991; Roitelman et al., 1991) . The Span7-HMGal mutant, however, is totally unresponsive to added sterols (Fig. 10) 
Discussion
In this report, we undertook an immunological approach to study the topology of the membrane domain of the ER glycoprotein HMG-CoA reductase, the rate-limiting enzyme in the cholesterogenic pathway. Such an approach has proven successful in studies of the topology of several membrane proteins (reviewed by Jennings, 1989) .
We describe the generation and characterization of monospecific rabbit antibodies against synthetic peptides derived from the membrane-bound domain of HMG-CoA reductase. Using these antibodies, we demonstrate that the sequences Arg224-Leu u2 and Thr~-Glu 3~ are on opposite sides of the ER membrane both in cultured CHO cells and in rat liver. We find that the region Arg224-Leu 242 (peptide G) faces the cytoplasm whereas peptide H (Thr284-Glu3~ resides, as expected from its proximity to the native N-glycosylation site, in the lumen of the ER. These results indicate that a sequence between Leu 242 and Thr 2u in the primary structure of hamster HMG-CoA reductase constitutes a previously unrecognized membrane spanning segment of the enzyme. This region, which appears as a minor spike in hydropathy plots of HMG-CoA reductase amino acid sequences from many species (Liscum et al., 1985; Skalnik and Simoni, 1985; Rajkovic et al., 1989) , was interpreted to be a part of an extended B-structure in the long lumenal loop that connects the putative 6th and 7th membrane spans in the model proposed by Liscum et al. (1985) .
We have recently shown that, in in vitro translation/translocation assays, this sequence (hereafter referred to as span 7, see Figs. 1 B and 11) exhibits some signal recognition particle-independent membrane association and has stop transfer activity. Also, the first transmembrane span of HMG-CoA reductase (residues 1-39), which acts as the signal sequence for the protein, assumes an N-cis orientation both in vitro and in vivo (Olender and Simoni, 1992) . Moreover, mutants of HMGal in which the native glycosylation site was eliminated and a new glycosylation site has been introduced separately into loops B, D, or F (see Fig. 1 B) were all glycosylated in vivo, whereas sites at loops C, E, or G were not. Taken together with the results presented here, these findings constitute evidence that the NH2 domain of HMG-CoA reductase spans the ER membrane eight times, as shown schematically in Fig. 11 . Consequently, the membrane spanning regions NH2-terminal to span 7 are reversed in their orientation, relative to the plane of the ER membrane, as compared to the 7 span model (Liscum et al., 1985) . We tested this conclusion directly using the mutant HMGal/Dins(A) in which the loop segment conn~ing membrane spans 3 and 4 was tagged with epitope H. The results Figure 5 . Anti-G antibody recognizes cytoplasmic epitopes in digitonin-permeabilized CHO-HMGal cells. CHO-HMGal cells were fixed and permeabilized with 10 #g/ml of digitonin, as described under Materials and Methods. In A, B, (7, and H, cells were further treated with 0.25% Triton X-100. Cells were doubly stained with a mixture of mouse anti-B-galactosidase (A, C, E, and G, rhodamine-labeled secondary antibodies) with either anti-H antibodies (B and D) or anti-G antibodies (F and H, FITC-labeled secondary antibodies). Each pair of panels was photographed with the same exposure time and prints were made with the same time and contrast values. clearly show that in its new position epitope H is still cryptic in the ER lumen, in agreement with the 8 membrane spans model.
The current analysis does not allow us to define the precise boundaries of span 7. It is possible that this span is very short, as has been suggested for several membrane spans of the o~ subunit of the E. coli F:F0-ATPase (Lewis et al., Figure 7 . Immunogold cytochemical localization of the G and H epitopes in rat liver sections. LRGold-embedded ultra-thin section of livers from rats fed a cholestyramine/compactin diet were incubated with anti-G (A) or anti-H (B) antibodies followed by goat antirabbit IgG conjugated to 5-nm colloidal gold, as described under 1990 ). Indeed, a stretch of 10 hydrophobic residues in this region (MetZ~s-Va1267) may agree with this possibility, if this core assumes an extended non-or-helical conformation. Such a membrane span would be flanked on both sides by a cluster of charged residues, consistent with the general structure of spanning regions of polytopic membrane proteins (Jennings, 1989) . Alternatively, it is reasonable that the sequence between prou9 or Val 252 and Ala 275 constitutes this 7th membrane span since it is preceded by the highly charged stretch
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and followed by a -DPSP.. , 5 residues NH2-terminal to the native glycosylation site at Asn TM (Fig. 11 ).
This region of 24-27 residues is of sufficient length to span the ER membrane in an a-helical configuration and contains the above mentioned hydrophobic core of 10 contiguous amino acids. In this model, however, there are five basic residues buried in the lipid bilayer (Fig. 11) (Chun and Simoni, 1992) was switched to Induction Medium 24 h before addition of sterols. A mixture of 25-hydroxycholesterol and cholesterol was given in ethanol (final concentration are 1.5/~g/ml and 15/~g/ml, respectively) in a staggered fashion, so that all time points could be assayed simultaneously. The B-galactosidase activity of the chimeric proteins was assayed as previously described (Skalnik et al., 1988) . the enzyme and of HMGal Skalnik et al., 1988; Chun et al., 1990) . The results presented in this report demonstrate the role of span 7 in this level of enzyme regulation. Replacement of wild type span 7 with the first membrane span of bacteriorhodopsin creates an enzyme with a short half-life, --2 h (Chun and Simoni, 1992; Roitelman and Simoni, unpublished results) , and completely abolishes the sterol-accelerated ER degradation of HMGal. Interestingly, a similar phenotype is created by deleting spans 4 and 5 in the membrane domains of HMG-CoA reductase and HMGal (Jingami et al., 1987; Skalnik et al., 1988; Chun and Simoni, 1992) . The replacement mutation, which introduces the sequence GWlWLALGTALMGLGTLYFLVKG in place of residues Gin 2s through Trp ~7a, does not disturb the intracellular targeting or transmembrane orientation of span 7-HMGal since the mutant enzyme is active and is localized correctly in the ER (Chun and Simoni, 1992) . However, this replacement eliminates most of the charged residues in this segment. Therefore, it is attractive to speculate that the charged residues in span 7 play a role in the sterol-regulated degradation of HMG-CoA reductase as they do in the ER degradation of the ot subunit of the T cell antigen receptor Bonifacino and Lippincott-Schwartz, 1991) . Possibly these residues are engaged in intramolecular charge interaction between adjacent membrane spans that might stabilize the enzyme or in intermolecular interactions involved in monomer-dimer interconversion between subunits of the reductase (Edwards et al., 1985; Ness et al., 1985; Roitelman and Shechter, 1986) , similar to the association between subunits of the T cell antigen receptor and CD3 . Alternatively, membrane span 7 may interact directly with sterols or indirectly with an auxiliary protein(s) that tag HMG-CoA reductase for degradation in response to sterols.
Liscum et al. have noted that in HMG-CoA reductase gene, as in the bovine rhodopsin gene (Nathans and Hoghess, 1983) , the introns are located near the junction of a membrane span and an external loop, such that each membrane span is separated from the adjacent span by a single intron (Liscum et al., 1985) . The position of intron 8 of the reductase gene (Reynolds et al., 1984) in span 7 conforms with this general relation between gene organization and protein structure (Fig. 11) .
HMG-CoA reductase and HMGal, large proteins of M, >1100,000, are rapidly degraded in the ER when sterols or mevalonate are added to the cells. The degradation pathway undertaken by these proteins, and the fate of the polypeptide chains during proteolysis is unknown. No degradation intermediates have been detected in pulse-chase experiments when immunoprecipitation was performed with antibodies directed against the cytoplasmic domains of reductase or of HMGal. Hence, detection and identification of such proteolyric fragments is essential for elucidating the process of regulated ER degradation. We anticipate that the antibodies against the membrane domain described in this report will prove useful also towards this goal.
